Retina Clinical Trials

129 recruitingLast updated: May 13, 2026

There are 129 actively recruiting retina clinical trials across 34 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Miami, Florida, United States, Shanghai, Shanghai Municipality, China, Ann Arbor, Michigan, United States. Updated daily from ClinicalTrials.gov.


Retina Trials at a Glance

129 actively recruiting trials for retina are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 43 trials, with the heaviest enrollment activity in Miami, Shanghai, and Ann Arbor. Lead sponsors running retina studies include National Eye Institute (NEI), Duke University, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

Treatments under study

About Retina Clinical Trials

Looking for clinical trials for Retina? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Retina trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Retina clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 129 trials

Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Retinal DiseaseGenotype
National Eye Institute (NEI)320 enrolled1 locationNCT01145196
Recruiting

Adaptive Optics Imaging of Outer Retinal Diseases

Age-Related Macular DegenerationRetinal DegenerationRetinitis Pigmentosa+7 more
Food and Drug Administration (FDA)100 enrolled2 locationsNCT05355415
Recruiting
Not Applicable

Head Positioning After Retina Detachment Repair

Retina; Detachment, Rhegmatogenous
University of Kansas Medical Center20 enrolled1 locationNCT03714503
Recruiting
Phase 1Phase 2

Disulfiram for Treatment of Retinal Degeneration

Inherited Retinal Dystrophy Primarily Involving Sensory Retina
University of Washington30 enrolled1 locationNCT05626920
Recruiting

Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA Images

Retina Pathology
Intalight, Inc30 enrolled1 locationNCT07568704
Recruiting
Not Applicable

Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

Diabetic RetinopathyRetinal Vein Occlusion
CHU de Reims120 enrolled1 locationNCT03680794
Recruiting

Cell Collection to Study Eye Diseases

Retinal DegenerationRetinitis PigmentosaRetinal Disease+1 more
National Eye Institute (NEI)930 enrolled1 locationNCT01432847
Recruiting
Not Applicable

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

Retinal Disease
University of Wisconsin, Madison50 enrolled1 locationNCT06380075
Recruiting

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

Diabete MellitusRetina Vein OcclusionAge Macular Degeneration
Ataturk University180 enrolled1 locationNCT07550777
Recruiting
Not Applicable

Defining Retinal Structures Using Hyperspectral Retinal Imaging

Retinal diseasesHealthy VolunteersAge-Related Macular Degeneration+2 more
Center for Eye Research Australia1,000 enrolled1 locationNCT07555574
Recruiting

Rod and Cone Mediated Function in Retinal Disease

Stargardt's DiseaseRetinal DegenerationRetinitis Pigmentosa
National Eye Institute (NEI)500 enrolled1 locationNCT02617966
Recruiting
Phase 1Phase 2

Oral Metformin for Treatment of ABCA4 Retinopathy

Retinal DegenerationRetinal DystrophyStargardt Disease+1 more
National Eye Institute (NEI)56 enrolled2 locationsNCT04545736
Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Retinitis PigmentosaInherited Retinal Degeneration
Jaeb Center for Health Research1,500 enrolled36 locationsNCT05589714
Recruiting

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Bayer50,000 enrolled1 locationNCT07308639
Recruiting
Not Applicable

Influence of Perfluorocarbon Liquid (LIQUID) During Pars Plana Vitrectomy on Retinal Vessel Displacement in Primary Macula-involving Rhegmatogenous Retinal Detachment

Retinal Displacement After Retinal Detachment Surgery
Norfolk and Norwich University Hospitals NHS Foundation Trust292 enrolled1 locationNCT07027098
Recruiting
Phase 1Phase 2

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Retinitis pigmentosa (RP)Retinal DegenerationPrimary Photoreceptor Disease+6 more
BlueRock Therapeutics54 enrolled4 locationsNCT06789445
Recruiting
Not Applicable

Functional IOL Implantation in Patients With Epiretinal Membrane

Epiretinal MembraneCataractIntraocular Lens Complication
Eye & ENT Hospital of Fudan University90 enrolled2 locationsNCT06719739
Recruiting

National Eye Institute Biorepository for Retinal Diseases

Age-Related Macular DegenerationDiabetic RetinopathyRetinal Disease+2 more
National Eye Institute (NEI)650 enrolled1 locationNCT01496625
Recruiting
Not Applicable

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Retinitis pigmentosa (RP)Stargardt DiseaseInherited Retinal Degeneration
Science Corporation5 enrolled1 locationNCT07266584
Recruiting
Phase 2

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled27 locationsNCT06627179